Generics 26

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Daunorubicin manufacturers

26 products found

Filters

26 products found
Few EU CTD dossiers available

daunorubicin + cytarabine

Injection 44 mg + 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISaudi Arabia, Libya, Saudi Arabia, South Korea, Turkey
Comments
Dossier Status: Upon request.Reference product: Vyxeos
Manufacturer #11907
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products for 20+ years. Key production lines include Rx, OTC, medical devices, and cosmetics. The company's production lines are EU GMP-compliant. The company owns branches in the EU, North America, and Africa.

Manufacturer usually replies in 4 days

daunorubicin

Vials, injection 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #16160

The company is a leading integrated pharmaceutical group specializing in traditional Asian medicine, chemical medicine, and biopharmaceutical products. It operates multiple subsidiaries and is recognized as a top innovator with state-of-the-art research facilities, including national engineering and technology centers. The company collaborates with over 100 research institutions globally and has received prestigious national awards for technological innovation and scientific progress. It maintains high standards of quality with certifications from ICH, FDA, and EDQM, and has passed national GMP authentication. The company focuses on innovation and service, aiming to strengthen its position in chemical pharmaceuticals, traditional Asian medicine, and biopharmaceuticals.

daunorubicin

Injection 50 mg/25 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Comments
Liposomal Injection
Manufacturer #30013
The company, established in 2016 and later restructured as a private limited entity in 2018, specializes in manufacturing APIs, advanced intermediates, and finished dosage forms. With robust relationships in the pharmaceutical industry, it has built a strong customer base of over 50 clients and achieved an annual turnover exceeding 200 crore. The company operates extensive facilities capable of scaling from lab-scale development to bulk production, supporting its global expansion strategy. Committed to ethical practices and social responsibility, the company aims to make healthcare affordable and accessible worldwide, with export markets across Asia, Latin America, and Africa.

Want to see all 26 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible